Search

Author/Creator Iapadre, N.

1. An elevated degree of genetic variability characterizes Hepatitis Delta Antigen (HDAg) and correlates with high levels of serum HDV-RNA: Implication for disease progression and design of new pharmacological targets. Issue 1 (16th February 2017)

Authors:
Colagrossi, L.; Salpini, R.; Scutari, R.; Battisti, A.; Piermatteo, L.; Bertoli, A.; Minichini, C.; Trimoulet, P.; Fleury, H.; Nebuloso, E.; De Cristofaro, M.; Cappiello, G.; Spanò, A.; Malagnino, V.; Mari, T.; Barlattani, A.; Iapadre, N.; Lichtner, M.; Mastroianni, C.M.; Lenci, I.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C. (February 2020)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Fabeni, L.; Teti, E.; Paolucci, S.; Minichini, C.; Aragri, M.; Rosa, K. Yu La; Carioti, L.; Pasquazzi, C.; Milana, M.; Foroghi, L.; Pollicino, T.; Licata, A.; Pieri, A.; Palitti, V. Pace; Bruzzone, B.; Micheli, V.; Bertoli, A.; Baiocchi, L.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. HBsAg mutations correlated with HCC in vivo affect HBsAg release and favor cell proliferation in vitro. (10th February 2016)

Authors:
Salpini, R.; Surdo, M.; Warner, N.; Cortese, M.F.; Mirabelli, C.; Colledge, D.; Soppe, S.; Saccomandi, P.; Pollicita, M.; Longo, R.; Romano, S.; Cappiello, G.; Spanò, A.; Trimoulet, P.; Fleury, H.; Vecchiet, J.; Iapadre, N.; Barlattani, A.; Bertoli, A.; Mari, T.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. HBV-HDV co-infection constrains HBV genetic evolution in HBsAg. (10th February 2016)

Authors:
Colagrossi, L.; Scutari, R.; Salpini, R.; Battisti, A.; Pollicita, M.; Bertoli, A.; Minichini, C.; Trimoulet, P.; Fleury, H.; Nebuloso, E.; De Cristofaro, M.; Cappiello, G.; Spanò, A.; Malagnino, V.; Sarmati, L.; Mari, T.; Barlattani, A.; Iapadre, N.; Lichtner, M.; Mastroianni, C.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli. (March 2023)

Authors:
Salpini, R.; Piermatteo, L.; Torre, G.; D'Anna, S.; Khan, S.; Duca, L.; Bertoli, A.; Malagnino, V.; Paba, P.; Ciotti, M.; Lenci, I.; Francioso, S.; Paquazzi, C.; Lichtner, M.; Mastroianni, C.; Santopaolo, F.; De Sanctis, G.; Marignani, M.; Pellicelli, A.; Galati, G.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection. (10th February 2016)

Authors:
Battisti, A.; Salpini, R.; Colagrossi, L.; Alteri, C.; Pollicita, M.; Ricciardi, A.; Cerva, C.; Maffongelli, G.; Lichtner, M.; Mastroianni, C.; Casinelli, K.; Paoloni, M.; Marignani, M.; Maylin, S.; Delaugerre, C.; Morisco, F.; Coppola, N.; Marrone, A.; Brega, A.; Francioso, S.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. In HBeAg-negative chronic HBV infection, HBsAg levels profoundly differ among HBV-genotypes and can be affected by the extent of HBsAg variability: Can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?. Issue 1 (16th February 2017)

Authors:
Salpini, R.; Battisti, A.; Anastasiou, O.; Gill, U.; Colagrossi, L.; Bertoli, A.; Fabeni, L.; Fini, V.; Piermatteo, L.; Iuvara, A.; Malagnino, V.; Cerva, C.; Lichtner, M.; Mastroianni, C.; De Sanctis, G.; Paoloni, M.; Marignani, M.; Pasquazzi, C.; Iapadre, N.; Mari, T.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Key mutations in HBsAg C-terminus correlate with lower HBsAg levels in vivo, hinder HBsAg release in vitro and affect HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection. (February 2019)

Authors:
Piermatteo, L.; Battisti, A.; Carioti, L.; Anastasiou, O.; Gill, U.S.; Colagrossi, L.; Bertoli, A.; Aragri, M.; Iuvara, A.; Malagnino, V.; Cerva, C.; Lichtner, M.; Mastroianni, C.M.; De Sanctis, G.M.; Maurizio, P.; Marignani, M.; Pasquazzi, C.; Iapadre, N.; Mari, T.; Parruti, G.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗